-
Mashup Score: 0Tralokinumab and the Skin Microbiome - 7 month(s) ago
Tralokinumab (Adbry) reduced Staphylococcus aureus (SA) bacteria and improved overall microbial diversity in the skin microbiome of adults with atopic dermatitis (AD). Researchers used data from ECZTRA 1, the large phase 3 study that previously demonstrated the effectiveness and safety of tralokinumab monotherapy for moderate-to-severe AD, for which the FDA approved the drug in 2021.
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 1Testing IL-23 Inhibitors in Difficult-to-Treat Psoriasis - 7 month(s) ago
IL-23 inhibitors showed high drug survival and effectiveness rates among patients with difficult-to-treat psoriasis. That’s the finding of a report published in the .
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
This study aimed to investigate the drug survival and effectiveness of IL-23 inhibitors in the treatment of #psoriasis and psoriatic #arthritis in a real-world setting. #AADReadingRoom @AADskin #dermatology Read more: https://t.co/hCJg6WKQf8 https://t.co/J7KtPjU6LD
-
-
Mashup Score: 0Adolescents, Atopic Dermatitis, and Upadacitinib: Efficacy, Safety - 7 month(s) ago
Adolescents with moderate-to-severe atopic dermatitis (AD) saw major improvements after taking upadacitinib (Rinvoq) for 16 weeks, according to an analysis appearing recently in . The study combined data from three separate phase 3 studies, collectively taking place in more than 20 countries and comprising 552 adolescents (290 female; 262 male).
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What did the data indicate regarding #upadacitinib use in this adolescent population? #AtopicDermatitis #AADReadingRoom @AADskin #dermatology Read more: https://t.co/IuictqUOAP https://t.co/DWWAho7VZE
-
-
Mashup Score: 0Problematic in Pregnancy? Part 2 - 8 month(s) ago
Few mourned the end of the FDA’s pregnancy risk letter categories for prescription and biologic drug labeling in 2015. In addition to being an oversimplified distillation of available safety data,
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
"Ideally, your staff can ask about #pregnancy plans as part of the intake, and flag it so that the dermatologist remembers to have the discussion.” #AADReadingRoom @AADskin #dermatology Read more: https://t.co/jFXkLasusw https://t.co/EH0bHgUUwn
-
-
Mashup Score: 1Psoriasis Treatment With Cyclosporine: A Guide for Patients - 8 month(s) ago
Cyclosporine was first approved to prevent the body from rejecting a transplanted organ. When given to organ-transplant recipients who had psoriasis, patients discovered that the medicine also effectively treated their psoriasis.
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
Why do dermatologists prescribe cyclosporine to treat #psoriasis? #Cyclosporine #AADReadingRoom @AADskin #dermatology Read more: https://t.co/5qsQBsafzp https://t.co/4nB1iPvA4g
-
-
Mashup Score: 0
Atopic eczema (AE) and psoriasis are often associated with mental health disorders in adulthood. But the specific factors underlying that connection remain elusive within the current body of research.
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What do we know now about the connections among these conditions, and how did this review advance this knowledge? #Psoriasis #Eczema #AADReadingRoom @AADskin #dermatology Read more: https://t.co/Q0MFludZgQ https://t.co/zq0MgBdtln
-
-
Mashup Score: 2Psoriasis Treatment: Methotrexate -- A Guide for Patients - 9 month(s) ago
Methotrexate is a strong medicine. The FDA approved it to treat adults with severe, disabling psoriasis that cannot be controlled with medicine applied to the skin or light treatments.
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
The FDA approved #methotrexate to treat adults with severe, disabling #psoriasis that cannot be controlled with medicine applied to the skin or light treatments. #AADReadingRoom @AADskin #dermatology Read more: https://t.co/xvfcoZI0fW https://t.co/PAeLAOnZkt
-
-
Mashup Score: 0IL-17 Blockers and Adverse Events in Patients With Psoriasis and Psoriatic Arthritis - 9 month(s) ago
A group of researchers wants clinicians to pay more attention to the adverse events (AE) associated with IL-17 inhibitors in people with psoriasis and psoriatic arthritis (PsA). Co-authors of a recent scoping review, published in , found that anti-IL-17 agents posed a significant risk of AEs, especially as their use continues to increase.
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What was the specific impetus for this review? #Psoriasis #Arthritis #AADReadingRoom @AADskin #dermatology Read more: https://t.co/CzR4AecSlG https://t.co/IXJN2t02qs
-
-
Mashup Score: 0JAK Inhibitors Bring Fast Itch Relief - 10 month(s) ago
Some patients saw reduced itching on the first day of treatment
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
What was the specific question this review was designed to explore? #JanusKinase #Itch #AADReadingRoom @AADskin #dermatology Read more: https://t.co/AklXxrPWPp https://t.co/5lB9HoFyfE
-
-
Mashup Score: 0Treatment Options for Pregnant Women Living With Eczema and Psoriasis - 10 month(s) ago
An American Academy of Dermatology Reading Room selection
Source: www.medpagetoday.comCategories: General Medicine News, Latest HeadlinesTweet-
"The potential for #motherhood requires constant vigilance in evaluating medical choices, which is why it's important for women living with #eczema and #psoriasis to partner with a board-certified dermatologist." #AADReadingRoom @AADskin #dermatology https://t.co/ajzuZGLNvj https://t.co/JjcdNF5WJP
-
What was the unanswered question you and your colleagues designed this investigation to address? #bacteria #AtopicDermatitis #AADReadingRoom @AADskin #dermatology Read more: https://t.co/Xq1UZy90jU https://t.co/HJgR7qVxRA